drug

ACT group therapy

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Vivantes Netzwerk für Gesundheit GmbH
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder
NCT06086184—Unknown

KOLs & investigators

1
Andreas Bechdolf, Prof. Dr.KOL score 11

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Vivantes Netzwerk für Gesundheit GmbH
company
trial
Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder
NA
trial
indication
Acceptance and Commitment Therapy
indication
Inpatients
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
KOL
Andreas Bechdolf, Prof. Dr.
KOL score 11
person